The Oncology Institute, Inc. (TOI) Reports Q2 Loss, Misses Revenue Estimates

The Oncology Institute, Inc. (TOI) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of$ 0.10. This compares to loss of $0.19 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -70%. A quarter ago, it was expected that this company would post a loss of$ 0.12 per share when it actually produced a loss of $0.22, delivering a surprise of -83.33%. Over the last four quarters, the company ...